FDA Adverse Event Injury Summary report: N

OPTISTAR LE INJECTOR SYSTEM

MDR report key: 3124676 · Received May 14, 2013

Report

Report Number
1518293-2013-00112
Event Type
Injury
Date Received
May 14, 2013
Date of Event
May 8, 2013
Report Date
May 14, 2013
Manufacturer
LIEBEL-FLARSHEIM CO.
Product Code
DXT
PMA / PMN Number
K073592
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

FIELD SERVICE ENGINEER (FSE) VERIFIED PRESSURE LIMITS, FLOW RATE, AND PROPER OPERATION PER OPTISTAR LE SERVICE MANUAL AND COMPLETED SYSTEM CHECK OUT PER SERVICE CHECKLIST 802848. UNIT PASSED CHECKOUT PROCEDURES AND WAS RETURNED TO SERVICE.

Description of Event or Problem · 1

ON (B)(6) 2013, CUSTOMER REPORTS VIA PHONE THAT WHILE PERFORMING A BREAST SCAN ON A FEMALE PT OF UNKNOWN AGE AN EXTRAVASATION OCCURRED. THE TECHNOLOGIST STOPPED THE INJECTION BEFORE FINISHING THE INJECTION. THIS FACILITY USED A 22# BD ANGIOCATH, MALLINCKRODT Y TUBING, AND A 60 CC BD SYRINGE. THE INJECTION SITE HAD SOME SWELLING, BUT ONLY APPROXIMATELY 10 CC EXTRAVASATED. THE PT WAS TREATED WITH A WARM COMPRESS AND RELEASED. PERTINENT MEDICAL HISTORY: PT STATED SHE HAD FRAGILE VEINS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
213894 OPTISTAR LE INJECTOR SYSTEM DXT LIEBEL-FLARSHEIM CO. OPTISTAR LE NA

Patients

Seq Age Sex Outcome Treatment
1 UNK